Sussman Norman 4
4 · DURECT CORP · Filed Oct 16, 2024
Insider Transaction Report
Form 4
DURECT CORPDRRX
Sussman Norman
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-10-14+104,000→ 104,000 totalExercise: $1.30Exp: 2034-10-14→ Common Stock (104,000 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three-month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.